Ulf Grawunder
Directeur/Membre du Conseil chez WUXI XDC CAYMAN INC.
Postes actifs de Ulf Grawunder
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| WUXI XDC CAYMAN INC. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| ADAGENE INC. | Directeur/Membre du Conseil | 01/04/2024 | - |
| Independent Dir/Board Member | 01/04/2024 | - | |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Directeur/Membre du Conseil | 18/04/2012 | - |
| Directeur des opérations | 03/08/2020 | - | |
| Fondateur | 18/04/2012 | - | |
| Directeur Général | 18/04/2012 | 03/08/2020 | |
| T-CURX GmbH | Directeur Général | 01/09/2022 | - |
| Fondateur | 01/09/2022 | - | |
Viopas Venture Consulting GmbH
 Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Corporate Officer/Principal | 01/01/2022 | - |
Historique de carrière de Ulf Grawunder
Anciens postes connus de Ulf Grawunder
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - | - |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Directeur Technique/Scientifique/R&D | 12/12/2002 | - |
| Fondateur | 17/07/2009 | - |
Formation de Ulf Grawunder
| University of Basel | Doctorate Degree |
| University of Bayreuth | Graduate Degree |
Statistiques
Internationale
| Suisse | 5 |
| Chine | 3 |
| Allemagne | 3 |
Opérationnelle
| Founder | 3 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WUXI XDC CAYMAN INC. | Commercial Services |
| ADAGENE INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
| T-CURX GmbH | |
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Finance |
- Bourse
- Insiders
- Ulf Grawunder
- Expérience
